NASDAQ:OMCL - US68213N1090 - Common Stock
The current stock price of OMCL is 32.59 USD. In the past month the price increased by 9.51%. In the past year, price decreased by -26.73%.
Symbol | Company Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
ABT | ABBOTT LABORATORIES | 27.07 | 230.89B | ||
ISRG | INTUITIVE SURGICAL INC | 58.79 | 169.67B | ||
BSX | BOSTON SCIENTIFIC CORP | 37.28 | 156.32B | ||
SYK | STRYKER CORP | 30.46 | 149.64B | ||
MDT | MEDTRONIC PLC | 16.78 | 119.05B | ||
BDX | BECTON DICKINSON AND CO | 13.52 | 55.31B | ||
IDXX | IDEXX LABORATORIES INC | 53.88 | 51.77B | ||
EW | EDWARDS LIFESCIENCES CORP | 31.65 | 47.75B | ||
RMD | RESMED INC | 28.74 | 40.19B | ||
GEHC | GE HEALTHCARE TECHNOLOGY | 15.82 | 33.66B | ||
DXCM | DEXCOM INC | 44.32 | 29.55B | ||
PHG | KONINKLIJKE PHILIPS NVR- NY | 16.42 | 26.56B |
Omnicell, Inc. engages in the provision of medication management automation solutions and adherence tools for healthcare systems and pharmacies. The company is headquartered in Fort Worth, Texas and currently employs 3,650 full-time employees. The company went IPO on 2001-08-08. The firm is focused on transforming pharmacy care through outcomes-centric innovation designed to optimize clinical and business outcomes across all settings of care through a portfolio of robotics, smart devices, intelligent software, and services. Its point of care automation solutions is designed to improve clinician workflows in patient care areas of the healthcare system, such as nursing units, patient wards, operating rooms, and emergency departments. The Company’s XT Series automated dispensing systems for medications and supplies, which are used in nursing units and other clinical areas of the hospital, are designed to support workflows specific to each area of the hospital, with various software and hardware options. For the operating room, the Company also offer specialized automated dispensing systems.
OMNICELL INC
4220 North Freeway
Fort Worth TEXAS 94043 US
CEO: Randall A. Lipps
Employees: 3670
Phone: 18774159990
The current stock price of OMCL is 32.59 USD. The price decreased by -2.07% in the last trading session.
The exchange symbol of OMNICELL INC is OMCL and it is listed on the Nasdaq exchange.
OMCL stock is listed on the Nasdaq exchange.
14 analysts have analysed OMCL and the average price target is 44.88 USD. This implies a price increase of 37.71% is expected in the next year compared to the current price of 32.59. Check the OMNICELL INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
OMNICELL INC (OMCL) has a market capitalization of 1.50B USD. This makes OMCL a Small Cap stock.
OMNICELL INC (OMCL) currently has 3670 employees.
OMNICELL INC (OMCL) has a support level at 32.58 and a resistance level at 33.21. Check the full technical report for a detailed analysis of OMCL support and resistance levels.
The Revenue of OMNICELL INC (OMCL) is expected to grow by 3.99% in the next year. Check the estimates tab for more information on the OMCL EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
OMCL does not pay a dividend.
OMNICELL INC (OMCL) will report earnings on 2025-10-28, before the market open.
The PE ratio for OMNICELL INC (OMCL) is 17.43. This is based on the reported non-GAAP earnings per share of 1.87 and the current share price of 32.59 USD. Check the full fundamental report for a full analysis of the valuation metrics for OMCL.
The outstanding short interest for OMNICELL INC (OMCL) is 4.44% of its float. Check the ownership tab for more information on the OMCL short interest.
ChartMill assigns a technical rating of 6 / 10 to OMCL. When comparing the yearly performance of all stocks, OMCL is a bad performer in the overall market: 83.61% of all stocks are doing better.
ChartMill assigns a fundamental rating of 4 / 10 to OMCL. Both the profitability and the financial health of OMCL get a neutral evaluation. Nothing too spectacular is happening here.
Over the last trailing twelve months OMCL reported a non-GAAP Earnings per Share(EPS) of 1.87. The EPS increased by 25.5% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | 2.01% | ||
ROA | 1.08% | ||
ROE | 1.83% | ||
Debt/Equity | 0.13 |
14 analysts have analysed OMCL and the average price target is 44.88 USD. This implies a price increase of 37.71% is expected in the next year compared to the current price of 32.59.
For the next year, analysts expect an EPS growth of -7% and a revenue growth 3.99% for OMCL